Automated drug design using synthetic DNA self-assembly | Science Communication from mdashf |

Using a simple “drag-and-drop” computer interface and DNA self-assembly techniques, Parabon NanoLabs researchers have developed a new automated method of drug development that could reduce the time required to create and test medications, with the support of an NSF Technology Enhancement for Commercial Partnerships grant.

Via Ray and Terry's , Dr. Stefan Gruenwald